Fig. 1 · Structure

Documents & Downloads

Hellebrin

Bufadienolide Compound

Hellebrin is a bufadienolide compound that primarily targets Na+/K+-ATPase, influencing intracellular signaling pathways. This compound exhibits significant anti-tumor activity by inhibiting cell growth and shows promise in overcoming apoptotic resistance in cancer cells. Additionally, Hellebrin has demonstrated anti-proliferative effects in multidrug-resistant cancer cell models, making it a valuable tool for cancer research and drug resistance studies.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer Adooq Bioscience
CAS Number 13289-18-4
Applications Bufadienolide Compound
Formula C36H52O15
Molecular Weight 724.79
SMILES
O=C1C=CC([C@H]2CC[C@@]3([C@@]4(CC[C@@]5(C[C@H](CC[C@@]5([C@]4(CC[C@]23C)[H])C=O)O[C@]6([C@H](O)[C@H](O)[C@@]([H])(O[C@H]7[C@H](O)[C@@H](O)[C@H](O)[C@H](O7)CO)[C@@H](O6)C)[H])O)[H])O)=CO1

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...